The Faces of Luminex: Robin Murphy, Systems Integration

The Luminex R&D teams for hardware, software, reagents, and assays operate mostly independently—which means we need great scientists to pull each of these elements together and ensure a seamless user experience. For this, we rely on Robin Murphy, Scientist II, who has been part of our family since 2006. He earned a bachelor’s in chemistry […]

Read More…

METHODS Special Issue: Multiplexing Protocol for Evaluating Biological Interactions with Nanoparticles

A new multiplexing protocol offers guidelines for measuring immunomodulatory effects of nanoparticles used in clinical applications Nanoparticles have the potential to deliver more targeted therapies to the exact location in the body where they’re most needed. To do this, it is essential to understand how these foreign particles interact with a patient’s body. A recent […]

Read More…

The Faces of Luminex: Martin Kochanczyk, Advanced Technologies Group

Our advanced technologies team is tasked with a mission that’s both challenging and fun: keeping Luminex at the cutting edge by figuring out what will be needed in the coming years and developing technology solutions to meet those needs. Physicist Martin Kochanczyk, Senior Manager of Technology Development, is one of the team members responsible for […]

Read More…